SEC EDGAR filings, ownership reports, and insider transactions for ARCH Venture Fund XII, L.P..
Recent SEC filings for ARCH Venture Fund XII, L.P. including 4, SCHEDULE 13D/A, SCHEDULE 13D and more.
| Form type | Document | Filing | Description | Filing date | Reporting date | File number(s) |
|---|---|---|---|---|---|---|
| 4 | Open 4 document | View SEC filing for 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 14 Nov 2025 | 13 Nov 2025 | 001-42489 |
| SCHEDULE 13D/A | Open SCHEDULE 13D/A document | View SEC filing for SCHEDULE 13D/A | 14 Nov 2025 | |||
| 4 | Open 4 document | View SEC filing for 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 29 Oct 2025 | 27 Oct 2025 | 001-41802 |
| SCHEDULE 13D/A | Open SCHEDULE 13D/A document | View SEC filing for SCHEDULE 13D/A | 29 Oct 2025 | |||
| SCHEDULE 13D/A | Open SCHEDULE 13D/A document | View SEC filing for SCHEDULE 13D/A | 11 Aug 2025 | |||
| 4 | Open 4 document | View SEC filing for 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 01 Aug 2025 | 01 Aug 2025 | 001-41536 |
| SCHEDULE 13D | Open SCHEDULE 13D document | Open XBRL data | View SEC filing for SCHEDULE 13D | 10 Feb 2025 | |||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 03 Feb 2025 | 03 Feb 2025 | 001-42489 |
| 3 | Open 3 document | View SEC filing for 3 | 3 | 30 Jan 2025 | 30 Jan 2025 | 001-42489 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | ARCH VENTURE FUND XII, L.P. - NEUMORA THERAPEUTICS -- SCH 13D/A(#2) | 22 Nov 2024 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | ARCH VENTURE FUND XII, L.P. - PRIME MEDICINE -- SCH 13D/A(#1) | 22 Nov 2024 | ||
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | ARCH VENTURE FUND XII, L.P. - RAPPORT THERAPEUTICS, INC. -- SCH 13G | 14 Nov 2024 | ||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 10 Jun 2024 | 10 Jun 2024 | 001-42121 |
| 3 | Open 3 document | View SEC filing for 3 | 3 | 06 Jun 2024 | 06 Jun 2024 | 001-42121 |
| SC 13D | Open SC 13D document | View SEC filing for SC 13D | ARCH VENTURE FUND XII, L.P. - PRIME MEDICINE -- SCH 13D | 22 Feb 2024 | ||
| 4 | Open 4 document | View SEC filing for 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 20 Feb 2024 | 15 Feb 2024 | 001-41536 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | ARCH VENTURE FUND XII, L.P. - NEUMORA THERAPEUTICS -- SCH 13D/A(#1) | 15 Dec 2023 | ||
| 4 | Open 4 document | View SEC filing for 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 12 Dec 2023 | 08 Dec 2023 | 001-41802 |
| 4 | Open 4 document | View SEC filing for 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 15 Nov 2023 | 13 Nov 2023 | 001-41802 |
| 4 | Open 4 document | View SEC filing for 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 13 Nov 2023 | 08 Nov 2023 | 001-41802 |
| 4 | Open 4 document | View SEC filing for 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 07 Nov 2023 | 03 Nov 2023 | 001-41802 |
| SC 13D | Open SC 13D document | View SEC filing for SC 13D | ARCH VENTURE FUND XII, L.P. - NEUMORA THERAPEUTICS -- SCH 13D | 02 Oct 2023 | ||
| 4 | Open 4 document | View SEC filing for 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 29 Sep 2023 | 28 Sep 2023 | 001-41802 |
| 4 | Open 4 document | View SEC filing for 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 27 Sep 2023 | 26 Sep 2023 | 001-41802 |
| 4 | Open 4 document | View SEC filing for 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 25 Sep 2023 | 22 Sep 2023 | 001-41802 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Sep 2023 | 19 Sep 2023 | 001-41802 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 14 Sep 2023 | 14 Sep 2023 | 001-41802 |
| D/A | Open D/A document | View SEC filing for D/A | 01 Apr 2022 | 021-432243 | ||
| D | Open D document | View SEC filing for D | 03 Feb 2022 | 021-432243 |
ARCH Venture Fund XII, L.P. files with the SEC under CIK 0001906837. This page aggregates EDGAR filings and related ownership activity.